Depression Habits Put Health At Risk, Study Finds TurnTo23.com, CA - Nov 26, 2008 Results from a new study following 1000 people with stable heart disease have shown that experts have good reason to be concerned: patients who had symptoms ...
Quick study News & Observer, NC - Nov 30, 2008 This study: randomly assigned 1276 people with Type 1 or Type 2 diabetes (average age, 60) but no symptoms of cardiovascular disease to take aspirin (100 ...
Drugs you can't have Stuff.co.nz, New Zealand - Nov 30, 2008 Here are a few of the good news stories: * Statins for heart disease: Around 300000 New Zealanders are now using cheap and effective anti- cholesterol drugs ...
Aspirin a Day Not for Diabetics NBC Dallas-Fort Worth, TX - Nov 23, 2008 By Nesita Kwan Many people take small doses of aspirin every day to try and prevent heart disease. But it may not provide the same benefit for people with ...
Money Motivates Doctors To Reduce Ethnic Differences In Heart... Science Daily (press release) - Nov 23, 2008 24, 2008) ? Financial incentives for doctors can improve the management of coronary heart disease (CHD) and reduce ethnic differences in quality of and ...
James LeFanu: Doctor's Diary Telegraph.co.uk, United Kingdom - Then, very importantly, this pattern of symptoms may be an unusual side effect of aspirin taken by many as a preventive measure against strokes and heart...
Vitamin C, E supplements won?t help prevent cancer The Punch, Nigeria - Nov 28, 2008 The same team also recently reported that vitamin C and E supplements weren?t helpful in protecting users against heart disease. ?At least in the context of ...
Recent News and Articles on the Keywords: aspirin + drug + heart Related to the article below (Last Update: 8/5/2008)
Pharma companies recyling old drugs for newer treatments Economic Times, India - ... dysfunction amongst men, is administered to women heart patients by altering the dosage. The common example for off-label usage of old drugs is aspirin. ...
Blood-Thinner Plavix Works Harder in Smokers U.S. News & World Report, DC - Aug 4, 2008 A standard recommendation for heart attack patients includes a year of combined therapy with Plavix and aspirin, another clot-preventing drug. ...
SpectraCell Laboratories Now Offers Aspirin Response Testing(TM) Earthtimes (press release), UK - Aug 4, 2008 Since studies show that individuals who do not respond to aspirin (in reducing platelet stickiness) are more than three times more likely to die from heart...
A Practical "ABCDE" Approach to the Metabolic Syndrome RedOrbit, TX - A comprehensive management plan can be assembled through an "ABCDE" approach: "A" for assessment of cardiovascular risk and aspirin therapy, "B" for blood ...
Peripheral Arterial Disease: Diagnosis and Management RedOrbit, TX - The patient is taking a beta-blocker, an angiotensinconverting enzyme (ACE) inhibitor, a statin, and aspirin. Which one of the following should be the next ...
Statins after heart attack NHS Choices, UK - Aug 4, 2008 This effect was not just due to stopping using a drug, as the same effect was not observed in people who stopped taking aspirin, beta blockers or PPIs. ...
Anti-inflammatory drugs could fight obesity Telegraph.co.uk, United Kingdom - Jul 14, 2008 Already, a small trial has been conducted, using a drug related to Aspirin, known as salsalate, which found that it improved the symptoms of diabetes ...
Cholesterol is the latest boogeyman in our kids' lives Rochester Democrat and Chronicle, NY - Aug 1, 2008 "We know that in adults, decreasing cholesterol and giving some of those drugs decreases risk of heart disease or death," one proponent told The New York ...
Aspirin and Clopidogrel Efficacy, Safety, and the Issue of Drug Resistance - M Cattaneo - Arteriosclerosis, Thrombosis, and Vascular Biology, 2004 - Am Heart Assoc ... both for secondary prevention of coronary heart disease. ... trial comparing three
antitrhombotic-drug regimens after ... of clopidogrel and aspirin versus ticlopidine ...
Potential cardioprotective actions of no-releasing aspirin. JL Wallace, LJ Ignarro, S Fiorucci - Nat Rev Drug Discov, 2002 - ncbi.nlm.nih.gov Nat Rev Drug Discov ... wallacej@ucalgary.ca The use of low doses of aspirin on a daily ...
observations that it can significantly reduce the risk of heart attacks and ...
People who take aspirin on a regular basis for heart disease should stop the drug 5 days before elective surgery to ensure that their blood is able to clot normally on the operative day.
In addition to its pain-relieving effects, aspirin inhibits the activity of platelets, cell-like structures in the blood that play a key role in clotting. This effect is beneficial for preventing clot-related diseases, such as heart attack and stroke, but it could spell problems during surgery.
Deciding when to stop aspirin therapy before surgery is a balancing act. If the drug is stopped too early, the patient could be at increased risk for clot-related problems. Conversely, discontinuing the drug too late, places the patient at risk for bleeding problems during the operation.
Dr. H. Paul Redmond, from Cork University Hospital in Ireland, and colleagues assessed clotting ability in 51 healthy volunteers who were randomly treated with aspirin, at one of two standard doses, or inactive "placebo" for 14 days. Data from 38 subjects was available for analysis.
The researchers’ findings appear in the Journal of the American College of Surgeons.
Clotting ability fell as expected in the aspirin groups during treatment, the investigators point out. Within 144 hours of stopping aspirin therapy, all of the subjects displayed normal clotting ability. This period before normal clotting returned was about the same regardless of the aspirin dose given.
Based on these findings, "we believe that aspirin therapy should be discontinued 5 days before elective surgery and the operation planned for the sixth day after treatment cessation. This should allow physicians and surgeons to minimize the risks of stopping aspirin without increasing the risk of excessive perioperative bleeding," the authors conclude.
Comment by Elizabeth G. Nabel M.D.
